Anthony Vendetti

Jeff Cohen

Jonathan Aschoff

Nicholas Sherwood

- Solana Company reported **over 2.3 million SOL** and **more than $15 million in cash and stablecoins** as of **October 29, 2025**.  **[1610853_0001104659-25-103714_hsdt-20251029xex99d1.htm:0]** 
- The company's SOL holdings increased by approximately **0.1 million** since its last update on October 6, 2025.  **[1610853_0001104659-25-103714_hsdt-20251029xex99d1.htm:0]** **[1610853_0001104659-25-103714_hsdt-20251029x8k.htm:1]** 
- For the month of October (through October 27th), the average gross staking yield was **7.03% APY**, outperforming the stake-weighted average of the top 10 validators by approximately **36 basis points**.  **[1610853_0001104659-25-103714_hsdt-20251029xex99d1.htm:0]**

Solana Company Announces Updated SOL Holdings and Staking Performance

- **Solana Company (HSDT)** is proceeding with the scheduled registration for resale of shares from a recent private placement, a decision made to establish a foundation of committed long-term shareholders and reach market equilibrium despite current market volatility.  **[1610853_0001104659-25-100920_hsdt-20251020xex99d1.htm:1]** 
- The company aims to be a leading Solana Digital Asset Treasury (DAT), offering institutional investors optimal exposure to Solana, and plans to maximize **SOL per share** through active accumulation and strategic capital deployment.  **[1610853_0001104659-25-100920_hsdt-20251020xex99d1.htm:1]** **[1610853_0001104659-25-100920_hsdt-20251020xex99d1.htm:2]** 
- Solana Company intends to generate **7%+ yield** via institutional-grade staking and will leverage capital markets to acquire additional Solana, with a long-term goal of becoming the "Berkshire Hathaway of the Solana ecosystem".  **[1610853_0001104659-25-100920_hsdt-20251020xex99d1.htm:1]**

Solana Company Executive Chairman Outlines Strategic Vision and Capital Allocation

- **Solana Company (HSDT)**, formerly Helius Medical Technologies, Inc., has entered into agreements with **Coinbase, BitGo, and Anchorage Digital** to serve as custodians for its digital assets treasury strategy.  **[1610853_c6e9a49087614ea78de42e8623290edf_0]** 
- This initiative is aimed at continuing to amass **SOL**, the native asset of the Solana Network, reflecting a disciplined and scalable approach to maximizing shareholder value and strengthening the foundation for HSDT’s strategy.  **[1610853_c6e9a49087614ea78de42e8623290edf_0]** 
- As an independent treasury company, HSDT's mission is to support the growth and security of tokenized networks by serving as a long-term holder of **$SOL**, alongside its ongoing neurotech and medical device operations.  **[1610853_c6e9a49087614ea78de42e8623290edf_0]**

Solana Company (HSDT) Adds Coinbase, BitGo, and Anchorage Digital as Custodians

- Helius Medical Technologies (HSDT) has continued its digital asset treasury strategy, accumulating over **2.2 million SOL** tokens.  **[1610853_faa9774fd4334745bfead80ea9ed1f9c_0]** 
- The company's combined Solana holdings (valued at **$232.50 per SOL** as of October 6th) and cash holdings, which exceed **$15 million**, now total over **$525 million**.  **[1610853_faa9774fd4334745bfead80ea9ed1f9c_0]** 
- This accumulation, which includes a ~**7% native staking yield** on SOL, has resulted in holdings exceeding the initial capital raise amount from the private placement that closed on **September 18th** in less than three weeks.  **[1610853_faa9774fd4334745bfead80ea9ed1f9c_0]** 
- HSDT aims to maximize shareholder value through this strategy, while also continuing its neurotech and medical device operations.  **[1610853_faa9774fd4334745bfead80ea9ed1f9c_0]** **[1610853_faa9774fd4334745bfead80ea9ed1f9c_1]**

Helius Medical Technologies Continues Solana Token Accumulation

- Helius Medical Technologies, Inc. (HSDT) has changed its corporate name to **Solana Company**, effective **September 29, 2025**, while retaining its **HSDT ticker symbol**.  **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex3-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_8k.htm:1]** 
- The company entered into a **non-binding letter of intent with the Solana Foundation**, committing to "Solana By Design" terms, which include conducting all on-chain activity solely on Solana (SOL) and engaging in joint initiatives.  **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_8k.htm:2]** 
- HSDT will have the option to **purchase SOL tokens from the Solana Foundation at a discount** and continues its digital asset treasury strategy, utilizing cash from a recent **$500 million PIPE financing**.  **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]**

Helius Medical Technologies, Inc. Announces Name Change to Solana Company and Letter of Intent with Solana Foundation

- **Helius Medical Technologies, Inc. (HSDT)** has officially changed its corporate name to **Solana Company**, with its ticker symbol **HSDT** remaining unchanged.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]** 
- The company has entered into a non-binding letter of intent with the **Solana Foundation**, committing to "Solana By Design" terms, which include conducting all on-chain activity solely on Solana and participating in joint initiatives.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]** 
- **Solana Company** will continue its digital asset treasury strategy of accumulating **SOL tokens**, intending to use cash from its recent **$500 million PIPE financing** for this purpose.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]** 
- The company's mission is to maximize **SOL per share** and deliver consistent on-chain yield for investors, aiming to accelerate the growth of Solana.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]**

HSDT Changes Name to Solana Company and Enters Agreement with Solana Foundation

- Helius Medical Technologies, Inc. (HSDT) has filed a **U.S. Food and Drug Administration (FDA) 510(k) submission** for the PoNS device label expansion, seeking an indication for **gait and balance deficit in patients with chronic stroke symptoms**.  **[1610853_0001104659-25-093161_hsdt-20250924xex99d1.htm:0]** **[1610853_0001104659-25-093161_hsdt-20250924x8k.htm:2]** 
- The submission is supported by data from the Stroke Registrational Program, which demonstrated the **superior effectiveness** of PoNS Therapy in improving gait deficit, achieving a statistically significant mean improvement of **5.37 points** in the Functional Gait Assessment (FGA) for the active treatment group compared to **3.31 points** for the control group.  **[1610853_0001104659-25-093161_hsdt-20250924xex99d1.htm:0]** 
- This filing was made under the company's existing **FDA Breakthrough Device Designation**.  **[1610853_0001104659-25-093161_hsdt-20250924xex99d1.htm:0]** **[1610853_0001104659-25-093161_hsdt-20250924x8k.htm:2]** 
- The company also entered into side letter agreements with its President and CEO, Dane C. Andreeff, and CFO, Jeffrey S. Mathiesen, providing **one-time discretionary cash bonuses** of **$890,000** and **$610,000**, respectively, in exchange for waiving certain change-in-control rights related to recent securities offerings.  **[1610853_0001104659-25-093161_hsdt-20250924x8k.htm:1]** **[1610853_0001104659-25-093161_hsdt-20250924xex10d1.htm:1]** **[1610853_0001104659-25-093161_hsdt-20250924xex10d2.htm:1]**

Helius Medical Technologies Files FDA 510(k) Submission for PoNS Device in Stroke and Announces Executive Bonuses

- Helius Medical Technologies, Inc. (HSDT) announced the initiation of its digital asset treasury strategy, with **Solana (SOL)** tokens as the principal holding.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]** 
- The company has acquired **over 760,190 SOL** at an average cost basis of **$231**.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]** 
- HSDT also holds **over $335 million in cash** designated for further digital asset treasury investments.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]** 
- This strategy aims to support tokenized network growth and security through long-term SOL holdings, complementing its neurotech and medical device operations.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]**

Helius Medical Technologies Initiates Solana (SOL) Digital Asset Treasury Strategy

- Helius Medical Technologies, Inc. closed a private placement offering on **September 18, 2025**, raising over **$500 million** in gross proceeds, with potential total proceeds exceeding **$1.25 billion** upon full warrant exercise.  **[1610853_0001104659-25-091281_tm2526455d1_ex99-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:1]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:7]** 
- The company will use the net proceeds to implement a new digital asset treasury strategy, acquiring **SOL**, the native cryptocurrency of the Solana blockchain, as its primary treasury reserve asset.  **[1610853_0001104659-25-091281_tm2526455d1_ex99-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:2]** 
- In connection with the offering, **Joseph Chee** (Founder and Chairman of Summer Capital) was appointed **Executive Chairman and Director**, and **Cosmo Jiang** (General Partner at Pantera Capital) was appointed as a **board observer**.  **[1610853_0001104659-25-091281_tm2526455d1_ex99-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:5]** 
- The company also increased its authorized shares of Class A Common Stock to **800,000,000** shares, effective **September 15, 2025**, to support its new strategic direction.  **[1610853_0001104659-25-091281_tm2526455d1_ex3-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:7]**

Helius Medical Technologies Secures Over $500M in Private Placement to Fund Solana Treasury Strategy

- Helius Medical Technologies (Nasdaq: HSDT) closed a private placement offering, generating **over $500 million** in gross proceeds, with an additional **$750 million** potentially available from warrant exercises, totaling **over $1.25 billion** in potential proceeds.  **[1610853_20250918SF77375:0]** 
- The company intends to use the net proceeds to implement a digital asset treasury strategy and acquire **SOL**, the native cryptocurrency of the Solana blockchain, which will serve as its primary treasury reserve asset.  **[1610853_20250918SF77375:0]** 
- The offering was led by **Pantera Capital** and **Summer Capital**, and Helius appointed **Joseph Chee** as Executive Chairman and Director, **Cosmo Jiang** as a board observer, and **Dan Morehead** as a Strategic Advisor.  **[1610853_20250918SF77375:0]** 
- Helius plans to build an initial SOL position and significantly scale holdings over the next **12-24 months**, evaluating staking and lending opportunities to generate revenue from the SOL Treasury.  **[1610853_20250918SF77375:1]**

Solana (HSDT)